Each filer's latest filing for 046513107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Adiumentum Capital Fund I LP
13D/A
|
20.0% |
5/16/2025
Event 5/14/2025
|
|
| Adiumentum Capital Fund I LP | 20.0% | ||
| Adiumentum Capital Fund I GP LLC | 20.0% | ||
| Gregory A. Ciongoli | 20.0% | ||
|
Panacea Innovation Ltd
13D/A
|
16.1% |
5/11/2026
Event 5/7/2026
|
|
| Panacea Innovation Limited | 16.1% | ||
| Panacea Venture Healthcare Fund II, L.P. | 12.4% | ||
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 12.4% | ||
| Panacea Opportunity Fund I, L.P. | 3.8% | ||
| Panacea Opportunity Fund I GP Company, Ltd. | 3.8% | ||
| James Huang | 16.1% |
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 28.0 | $321 |
| 2026 Q1 | 1 | 28.0 | $132 |
| 2025 Q3 | 1 | 15.0 | $215 |
| 2024 Q4 | 2 | 63.0 | $839 |
| 2024 Q3 | 1 | 35.0 | $285 |
| 2024 Q2 | 5 | 182 k | $1.51M |
| 2024 Q1 | 83 | 87.3 M | $60.7M |
| 2023 Q4 | 92 | 69.3 M | $35.5M |
| 2023 Q3 | 111 | 88.2 M | $131M |
| 2023 Q2 | 119 | 90.5 M | $146M |
| 2023 Q1 | 126 | 103 M | $298M |
| 2022 Q4 | 141 | 105 M | $345M |
| 2022 Q3 | 156 | 100 M | $378M |
| 2022 Q2 | 136 | 99.8 M | $778M |
| 2022 Q1 | 148 | 97.9 M | $910M |
| 2021 Q4 | 140 | 95.6 M | $1.51B |
| 2021 Q3 | 141 | 89.7 M | $1.61B |
| 2021 Q2 | 146 | 86.0 M | $1.34B |
| 2021 Q1 | 152 | 86.7 M | $1.24B |
| 2020 Q4 | 150 | 87.6 M | $1.72B |
| 2020 Q3 | 142 | 83.8 M | $1.09B |
| 2020 Q2 | 125 | 77.8 M | $1.13B |
| 2020 Q1 | 113 | 63.0 M | $536M |
| 2019 Q4 | 119 | 62.0 M | $1.02B |
| 2019 Q3 | 115 | 59.0 M | $833M |
| 2019 Q2 | 119 | 50.5 M | $1.01B |
| 2019 Q1 | 125 | 48.9 M | $1.94B |
| 2018 Q4 | 126 | 48.8 M | $1.69B |
| 2018 Q3 | 120 | 47.1 M | $1.95B |
| 2018 Q2 | 128 | 47.0 M | $1.73B |
| 2018 Q1 | 120 | 43.9 M | $1.71B |
| 2017 Q4 | 89 | 29.9 M | $542M |
| 2017 Q3 | 84 | 26.6 M | $441M |
| 2017 Q2 | 88 | 25.7 M | $360M |
| 2017 Q1 | 87 | 24.1 M | $496M |
| 2016 Q4 | 87 | 23.3 M | $331M |
| 2016 Q3 | 77 | 22.4 M | $479M |
| 2016 Q2 | 74 | 21.8 M | $493M |
| 2016 Q1 | 73 | 19.8 M | $377M |
| 2015 Q4 | 87 | 19.3 M | $510M |
| 2015 Q3 | 91 | 20.1 M | $644M |
| 2015 Q2 | 76 | 13.2 M | $696M |
| 2015 Q1 | 54 | 11.2 M | $462M |
| 2014 Q4 | 41 | 6.76 M | $173M |